Is this you? Create Your Porfile
Avatar

Klaus Bornemann

Boehringer Ingelheim

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Klaus Bornemann is active.

Explore More

Publication

Featured researches published by Klaus Bornemann.

Archive | 2002

Novel tri-substituted pyrimidines, method for production and use thereof as medicament

Frank Himmelsbach; Klaus Fuchs; Hans Briem; Katja Fechteler; Markus Kostka; Cornelia Dorner-Ciossek; Klaus Bornemann; Klaus Klinder

Archive | 2006

Substituted ethane-1,2-diamines for the treatment of alzheimer's disease ii

Stefan Peters; Christian Eickmeier; Klaus Fuchs; Werner Stransky; Cornelia Dorner-Ciossek; Marcus Kostka; Sandra Handschuh; Herbert Nar; Klaus Bornemann; Klaus Klinder; Margit Bauer

Archive | 2005

Method of treating diseases and conditions associated with an altered level of amyloid beta peptides and new enolcarboxamide compounds

Klaus Bornemann; Guenter Trummlitz; Bernd Beck; Frank Sams-Dodd; Dagmar Kugler; Klaus Klinder; Cornelia Dorner-Ciossek; Marcus Kostka

Archive | 2002

Muscarinic M1 agonist as an inhibitor of beta-amyloid (Aβ40 and Aβ42)-synthesis

Christoph Hock; Andreas Raschig; Marion Wienrich; Roger Nitsch; Klaus Mendla; Dieter Horst Meier; Klaus Bornemann; Cornelia Dorner-Ciossek

Archive | 2005

Treatment of diseases associated with altered level of amyloid beta peptides

Klaus Bornemann; Guenter Trummlitz; Edward S. Lazer; Clara K. Miao; Bernd Beck; Frank Sams-Dodd; Dagmar Kugler; Klaus Klinder; Cornelia Dorner-Ciossek; Marcus Kostka

Archive | 2005

Monoamine neurotransmitter re-uptake inhibitor for the inhibition of beta-amyloid generation

Klaus Bornemann; Joachim Mierau; Dagmar Kugler

Archive | 2005

MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITOR FOR THE INHIBITION OF BETA-AMYLOID (Aß40 AND Aß42) -GENERATION

Klaus Bornemann; Joachim Mierau; Dagmar Kugler

Archive | 2006

Monoamine neurotransmitter re-uptake inhibitors for neuroprotection in patients suffering from an advanced stage of a mental disease

Klaus Bornemann; Holger Rosenbrock; Frank Sams-Dodd; Bastian Hengerer; Jens D. Mikkelsen

Archive | 2006

Inhibiteur de recaptage de neurotransmetteur monoamine pour la neuroprotection

Klaus Bornemann; Holger Rosenbrock; Frank Sams-Dodd; Bastian Hengerer; Jens D. Mikkelsen

Archive | 2006

Inhibiteurs du recaptage du neurotransmetteur monoamine pour une neuroprotection chez des patients souffrant d'une maladie mentale avancée

Klaus Bornemann; Holger Rosenbrock; Frank Sams-Dodd; Bastian Hengerer; Jens D. Mikkelsen

Explore More

Collaboration

Dive into the Klaus Bornemann's collaboration.

Top Co-Authors
Avatar

Cornelia Dorner-Ciossek

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Dagmar Kugler

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Klaus Klinder

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Joachim Mierau

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Klaus Fuchs

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Bastian Hengerer

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Frank Himmelsbach

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Hans Briem

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Holger Rosenbrock

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Katja Fechteler

Boehringer Ingelheim

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge